The content on this page is intended for members of the public.

Our current prescription medicines are listed below. If you click on the links below, you will be redirected to the Medicines and Healthcare products Regulatory Agency (MHRA), which contains easily accessible information about licensed medicines available in the United Kingdom. The MHRA website contains the Summary of Product Characteristics (SPC) and Patient Information Leaflets (PIL) for our medicines.

ORLADEYO® (berotralstat) Logo

ORLADEYO® (berotralstat) SPC and PIL

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may develop. See yellowcard.mhra.gov.uk for how to report side effects.

 

Reporting of side effects

If you develop any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of this medicine.

 

Medical enquiries

For medical enquiries relating to our products please contact our Medical Information team at medinfoeurope@biocryst.com or +44 (0)20 3885 0789.